EUVIMEDAvasta EUVIMED
Video/Audio

The Regimen of Cladribine, Cytarabine, and Venetoclax (CAV) Induces Apoptosis in Acute Myeloid Leukemia Cells by Enhancing DNA Damage

Fang-Tong Liu, Yuan-Hong Huang, Shuai-Shuai Ge, Chao-Ling Wan, Miao Wang, Zhi-Zhi Zhang, Yan-Yan Li, Hai-Hui Liu, Hong-Feng Pang, Xiao-Yu Lyu, Zheng Li, Hai-Ping Dai and 2 more

Journal of Visualized Experiments · 2026

DOI: 10.3791/69797 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, 2026. Written by Fang-Tong Liu and 13 co-authors. Institution: National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University; Ins…. Major MEDLINE topics: Leukemia, Myeloid, Acute, Apoptosis, DNA Damage, Antineoplastic Combined Chemotherapy Protocols. 21 references.

AbstraktSubjectsBibliograafilised andmedCiteRelated studies

Abstract (original language)

Patients with primary refractory or relapsed acute myeloid leukemia (AML) typically face a poor prognosis. Current chemotherapy regimens do not always achieve complete remission (CR) before transplantation, while facing the dilemma of high organ toxicity and no chance of transplantation in some patients. A combination of cladribine, cytarabine, and venetoclax (CAV) represents a novel salvage regimen. In this study, cladribine, cytarabine, and venetoclax alone or in combination significantly inhibited the proliferation of leukemia cell lines and primary cells in a dose-dependent manner, with the triple CAV combination exerting a far stronger inhibitory effect than any single agent or dual-drug combination (p < 0.01) and showing synergistic interactions (combination index

Subjects

MeSH terms (MEDLINE)

Leukemia, Myeloid, AcuteApoptosisDNA DamageAntineoplastic Combined Chemotherapy ProtocolsHumansCytarabineCladribineSulfonamidesBridged Bicyclo Compounds, HeterocyclicCell Line, Tumor

Substances

CytarabineCladribinevenetoclaxSulfonamidesBridged Bicyclo Compounds, Heterocyclic

Authors and institutions

  • National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University; Institute of Blood and Marrow Transplantation, Collaborative Innovation C…
  • Jiangsu Province Engineering Research Center of Development and Translation of Key Technologies for Chronic Disease Prevention and Control, Suzhou Vocational Health College; liusongbai@126.com.

Cite

APA

Liu, F. T., Huang, Y. H., Ge, S. S., Wan, C. L., Wang, M., Zhang, Z. Z., Li, Y. Y., Liu, H. H., Pang, H. F., Lyu, X. Y., Li, Z., Dai, H. P., Liu, S. B., & Xue, S. L. (2026). The Regimen of Cladribine, Cytarabine, and Venetoclax (CAV) Induces Apoptosis in Acute Myeloid Leukemia Cells by Enhancing DNA Damage. Journal of Visualized Experiments. https://doi.org/10.3791/69797

Vancouver

Liu FT, Huang YH, Ge SS, Wan CL, Wang M, Zhang ZZ, et al. The Regimen of Cladribine, Cytarabine, and Venetoclax (CAV) Induces Apoptosis in Acute Myeloid Leukemia Cells by Enhancing DNA Damage. Journal of Visualized Experiments. 2026. doi:10.3791/69797

BibTeX
@article{Liu2026,
  author = {Liu, Fang-Tong and Huang, Yuan-Hong and Ge, Shuai-Shuai and Wan, Chao-Ling and Wang, Miao and Zhang, Zhi-Zhi and Li, Yan-Yan and Liu, Hai-Hui and Pang, Hong-Feng and Lyu, Xiao-Yu and Li, Zheng and Dai, Hai-Ping and Liu, Song-Bai and Xue, Sheng-Li},
  title = {The Regimen of Cladribine, Cytarabine, and Venetoclax (CAV) Induces Apoptosis in Acute Myeloid Leukemia Cells by Enhancing DNA Damage},
  journal = {Journal of Visualized Experiments},
  year = {2026},
  doi = {10.3791/69797}
}
Start for free →